Centre for Policy on Ageing
 

 

Economic impact of Alzheimer's disease in the United Kingdom
 — cost of care and disease severity for non-institutionalised patients with Alzheimer's disease
Author(s)E Souêtre, R M A Thwaites, H L Yeardley
Journal titleThe British Journal of Psychiatry, vol 174, January 1999
Pagespp 51-55
KeywordsDementia ; Patients ; Family care ; Costs [care] ; Econometrics ; Cross sectional surveys.
AnnotationWhile the costs associated with Alzheimer's disease (AD) have been shown to be significant, there are few data relating cost of care to severity of the disease. In this cross-sectional, multi-centre, naturalistic analysis, the authors aimed to compare the costs associated with different severities of AD with those incurred by control subjects over a 3-month period. 128 non-institutionalised patients with AD, their care-givers, and 56 matched controls were interviewed once to establish resource use over the previous 3 months. Patients were stratified according to three severity groups according to their Mini Mental State Examination (MMSE) score. Costs were calculated from the perspective of society as a whole. Over the 3-month period, total mean cost per control subject (£378) was minor, compared with mean cost incurred by mild (£6,616), moderate (£10,230), and severe (£13,593) AD. Indirect cost, mainly time spent by care-givers, was the main cost component in all groups (68.6%), followed by direct medical costs (24.7%). The cost of care for an AD patient is directly related to the severity of the patient's illness. (RH).
Accession NumberCPA-990119004 A
ClassmarkEA: LF: P6:SJ: QDC: WE: 3KB

Data © Centre for Policy on Ageing

...from the Ageinfo database published by Centre for Policy on Ageing.
 

CPA home >> Ageinfo Database >> Queries to: webmaster@cpa.org.uk